Fujisawa Kanagawa, Japan

Yoshihisa Nakada

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Osaka, JP (2013)
  • Kanagawa, JP (2014)
  • Fujisawa, JP (2020)
  • Fujisawa Kanagawa, JP (2021 - 2023)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Yoshihisa Nakada

Introduction

Yoshihisa Nakada, an accomplished inventor based in Fujisawa, Kanagawa, Japan, has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, Nakada's work focuses primarily on innovative methods and compounds that have the potential to improve treatments for various diseases.

Latest Patents

Among his latest patents, Nakada has developed methods for making a cyclic dinucleotide, which possesses STING agonistic activity. This compound may serve as a valuable agent for the prophylaxis or treatment of STING-related diseases. The patent details a compound represented by a specific formula, where each symbol is defined within the provided description. Additionally, he holds a patent for antibody-drug conjugates that also encompass this cyclic dinucleotide, further emphasizing its potential utility in therapeutic applications.

Career Highlights

Yoshihisa Nakada is affiliated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role at Takeda allows him to harness the resources and collaborative environment necessary to develop groundbreaking therapies. Over the years, Nakada's innovative approach has established him as a notable figure in the world of pharmaceutical research.

Collaborations

Throughout his career, Nakada has collaborated with esteemed colleagues such as Tomohiro Seki and Masato Yoshikawa. These partnerships have played a crucial role in advancing his research and furthering the development of new therapeutic strategies.

Conclusion

Yoshihisa Nakada's inventive spirit and dedication have significantly impacted the pharmaceutical industry. With multiple patents highlighting his research on cyclic dinucleotides and their potential applications, he continues to pave the way for advancements in the treatment of various diseases. As he collaborates with talented professionals at Takeda Pharmaceutical Company Limited, Nakada's contributions will undoubtedly shape the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…